Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
Juli Secures $3.8 Million for AI-powered Platform to Help Manage Chronic Conditions
juli, the AI-powered digital health platform empowering patients and their care teams to manage complex […]
Rondo Therapeutics Closes $67 Million Series A Financing to Advance Next-Generation Immuno-Oncology Platform for Solid Tumors
Rondo Therapeutics, a biopharmaceutical company advancing a next-generation immuno-oncology platform for treating solid tumors, today […]
Privo Technologies, Inc. Awarded $2.5M from National Cancer Institute for its Intraoperative Treatment of Solid Tumors
Privo Technologies, Inc. (“Privo”, “the Company”), a clinical stage biopharmaceutical company focused on optimizing state-of-the-art oncology […]
Supira Medical, a Shifamed Portfolio Company, Closes $30M in an Oversubscribed Series C Financing
Supira Medical, Inc., a Shifamed portfolio company that is focused on developing a next-generation solution […]
BIORCHESTRA Announces 45 Million USD Series C Fundraising
BIORCHESTRA is a leading RNA therapeutics company whose lead programs focus on neurodegenerative diseases using […]
TargED Biopharmaceuticals Raises EUR 39 Million in Series A Financing to Bring Groundbreaking Thrombolytic Treatment to Patients
TargED Biopharmaceuticals (“TargED”), a private biotechnology company focused on developing improved treatments for thrombotic diseases, […]
SpliceBio Raises EUR 50M in Oversubscribed Series A financing to Advance Protein Splicing Platform and Expand Gene Therapy Pipeline
SpliceBio, a biotechnology company exploiting protein splicing to develop next generation gene therapies, today announced […]
Aelis Farma Announces the Success of its Initial Public Offering and Raises Approximately €25 Million on Euronext Paris
Aelis Farma, a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases […]
OxDX Raises £2.6M Pre-seed Funding to Develop AI Powered Rapid Diagnostic Technology
OxDX, a University of Oxford spin out building instant pathogen tests using super-resolution microscopy and […]
Technology-Driven Precision Medicine Company Variantyx Secures $41.5M in Funding
Variantyx, a technology-driven precision medicine company providing advanced genomic testing for the rare genetic disorders, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more